Kidney cancer, version 3.2015: Featured updates to the NCCN guidelines Review uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms

abstract

  • The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.

authors

publication date

  • January 2015

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 25691606

Additional Document Info

start page

  • 151

end page

  • 9

volume

  • 13

number

  • 2